Predictive Signature of Benralizumab Response

Clinical trial NCT04565483 · RECRUITING

Trial details

NCT number: NCT04565483
Sponsor: Nantes University Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Asthma; Eosinophilic Severe Asthma

Start date: 2021-10-11
Primary completion: 2026-10-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.